Group One Trading
OLMA icon

Group One Trading’s Olema Pharmaceuticals OLMA Stock Holding History

Group One Trading’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$677K Sell
45,400
-75,100
-62% -$1.67M ﹤0.01% 3055
2025
Q4 		$3.01M Buy
120,500
+16,000
+15% +$285K 0.01% 1919
2025
Q3 		$1.02M Buy
104,500
+104,400
+104,400% +$627K ﹤0.01% 3009
2025
Q2 		$426 Buy
+100
New +$446 ﹤0.01% 7680
2025
Q1 		– Sell
-15,400
Closed -$89.8K – 8140
2024
Q4 		$89.8K Sell
15,400
-76,600
-83% -$765K ﹤0.01% 4614
2024
Q3 		$1.1M Buy
92,000
+9,500
+12% +$121K ﹤0.01% 2216
2024
Q2 		$893K Buy
82,500
+81,700
+10,213% +$886K ﹤0.01% 2080
2024
Q1 		$9.06K Sell
800
-18,100
-96% -$234K ﹤0.01% 5920
2023
Q4 		$265K Buy
18,900
+12,900
+215% +$173K ﹤0.01% 3609
2023
Q3 		$74.1K Buy
6,000
+5,100
+567% +$52K ﹤0.01% 4734
2023
Q2 		$8.13K Buy
+900
New +$5.43K ﹤0.01% 6494
2022
Q4 		– Sell
-5,200
Closed -$14K – 7848
2022
Q3 		$14K Buy
5,200
+5,000
+2,500% +$21.2K ﹤0.01% 6301
2022
Q2 		$1K Buy
+200
New +$634 ﹤0.01% 7593

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Group One Trading's OLMA Position: Q1 2026 in Review

Group One Trading opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 37,180 shares worth $554K. The stake represents ﹤0.01% of the portfolio and ranks #3246 among its holdings. This is a return to the name: Group One Trading previously reported a position in OLMA as recently as Q2 2025.

Group One Trading first reported a position in OLMA in Q4 2021 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Group One Trading held 37,180 shares of Olema Pharmaceuticals worth $554K as of Q1 2026.
  • Olema Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3246 holding.
  • Group One Trading first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 7 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.